Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws

Gupta, Sumedha; Nguyễn, Thủy; Freeman, Patricia R.; Simon, Kosali

doi:10.3386/w27520

Cited by 8 publications

(6 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Seven weeks after tramadol's scheduling, the leading opioid form on the market, hydrocodone combination products, was moved from level III to the more restricted level II (where no refills are allowed). Gupta et al (2020) find that the tightening of these prescribing restrictions decreased their use, but also caused some increases in prescriptions of close competitors. As a result, there was no statistically detectable short-run reduction in total number of opioid prescriptions.…”

Section: Other Supply-side Policiesmentioning

confidence: 89%

Economic Studies on the Opioid Crisis: A Review

et al. 2020

View full text Add to dashboard Cite

Section: Other Supply-side Policiesmentioning

confidence: 89%

Economic Studies on the Opioid Crisis: A Review

et al. 2020

View full text Add to dashboard Cite

“…10 The time series of adoption dates of must-access prescription drug monitoring program laws (PDMPs) in each of the fifty US states was constructed using four established sources - (Sacks et. al, 2021;Gupta et. al, 2020).…”

Section: Datamentioning

confidence: 99%

The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes

Gupta¹,

Mazumder²

2023

View full text Add to dashboard Cite

We examine how the availability of prescription opioids affects labor market activity and household economic well-being. While greater access to opioids may lead people to substance use disorders and negative economic consequences, appropriate pain medication may allow some individuals to effectively participate in the labor market. We study prescription drug monitoring programs (PDMPs), which were designed to curb inappropriate opioid prescribing and assess how these policies affected labor force attachment and credit outcomes. We use variation across states in the timing of implementation of PDMPs and recent methods developed for difference-in-difference event study designs with multiple time periods. In line with previous work, we find that PDMPs lead to a decline in opioid prescribing rates. Although we find that these reductions in opioid supply have no clear effect on measures of labor force activity in our pooled sample, we see some suggestive evidence of negative effects on labor force attachment in states where there is less scope for substitution to illicit drugs. We also show that PDMPs lead to a decline in credit scores and increases in the number and amount of third-party debt collections, and that these effects are more pronounced in states lacking an illicit market. These findings suggest that some individuals are likely negatively affected by the lack of access to pain medication due to the PDMP laws.

show abstract

“…Code 540-X-17-.03). Third, many states have their own version of the federal Controlled Substances Act, and states need not perfectly duplicate the federal scheduling process (Gupta et al, 2020).…”

Section: Prescriptive Authoritymentioning

confidence: 99%

Toward a Uniform Classification of Nurse Practitioner Scope of Practice Laws

McMichael

Markowitz

2022

Med Care Res Rev

View full text Add to dashboard Cite

Many states’ scope of practice laws limits the ability of nurse practitioners to deliver care by requiring physician supervision of their practices and prescribing activities. A robust literature has evolved around examining the role of these scope of practice laws in various contexts, including labor market outcomes, health care access, health care prices, and the delivery of care for specific diseases. Unfortunately, these studies use different, and sometimes conflicting, measures of scope of practice laws, limiting their comparability and overall usefulness to policymakers and future researchers. We address this salient problem by providing a recommended coding of nurse practitioner scope of practice laws over a 24-year period based on actual statutory and regulatory language. Our classification of scope of practice laws solves an important problem within this growing literature and provides a solid legal foundation for researchers as they continue to investigate the effects of these laws.

show abstract

Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws

Cited by 8 publications

References 38 publications

Economic Studies on the Opioid Crisis: A Review

Economic Studies on the Opioid Crisis: A Review

The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes

Toward a Uniform Classification of Nurse Practitioner Scope of Practice Laws

Contact Info

Product

Resources

About